Market Share of Gram-positive Bacterial Infections Industry
The gram-positive bacterial infections market is competitive and consists of many players operating globally and regionally. However, the large layers of the industry are vertically integrated. Some of the companies which are currently dominating the market are GlaxoSmithKline Plc, Johnson & Johnson Inc., Merck & Co. Inc., Pfizer Inc., AstraZeneca, Cumberland Pharmaceuticals, Novartis AG, Sanofi SA, Sun Pharmaceutical Industries Ltd., Cipla Ltd., Bayer AG, and Bristol-Myers Squibb Company.
Gram Positive Bacterial Infections Market Leaders
-
Novartis AG
-
Pfizer
-
Cipla
-
Merck & Co. Inc.
-
GlaxoSmithKline Plc
*Disclaimer: Major Players sorted in no particular order
![Gram Positive Bacterial Infection Market Concentration](https://s3.mordorintelligence.com/gram-positive-bacterial-infections-market/gram-positive-bacterial-infections-market_1669100602083_Gram_Positive_Bacterial_Infection_Market.webp)